Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer

Cannabidiol, a major non-psychotomimetic compound derived from Cannabis sativa, is a potential therapeutic agent for a variety of diseases such as inflammatory diseases, chronic neurodegenerative diseases, and cancers. Here, we found that the combination of cannabidiol and TNF-related apoptosis-indu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancers (Basel)
Päätekijät: Kim, Jung Lim, Kim, Bo Ram, Kim, Dae Yeong, Jeong, Yoon A., Jeong, Soyeon, Na, Yoo Jin, Park, Seong Hye, Yun, Hye Kyeong, Jo, Min Jee, Kim, Bu Gyeom, Kim, Han Do, Kim, Dae Hyun, Oh, Sang Cheul, Lee, Sun Il, Lee, Dae-Hee
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562873/
https://ncbi.nlm.nih.gov/pubmed/31075907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050642
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia